McKesson Corporation Fights a Clawback Policy Proposed by Big Investors
7/30/2013 7:09:10 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Should one of the largest drug wholesalers have a clawback policy for executives? Two institutional investors believe the notion is overdue for McKesson, since the wholesaler has paid more than $1 billion in recent years to resolve regulatory and other legal disputes without publicly disclosing any clawback steps. Meanwhile, McKesson ceo John Hammergren received $131 million in compensation last year. And so, the LongView Funds run by Amalgamated Bank and the UAW Retiree Medical Benefits Trust are pushing a proposal to be voted on at the McKesson annual shareholder meeting tomorrow.
Help employers find you! Check out all the jobs and post your resume.
comments powered by